Permeability, ultrastructural changes, and distribution of novel proteins in the glomerular barrier in early puromycin aminonucleoside nephrosis

Nephron - Experimental Nephrology

Volumn 116, Issue 2, 2010, Pages

  Dunér, Fredrik ^a,e   Lindström, Karin ^a   Hultenby, Kjell ^b   Hulkko, Jenny ^b   Patrakka, Jaakko ^c   Tryggvason, Karl ^c   Haraldsson, Börje ^d   Wernerson, Annika ^b   Pettersson, Erna ^a  

^a Division of Renal Medicine   (United States)

^b Laboratory Medicine   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Foot process effacement; Glomerular barrier; Nephrin; Novel proteins, distribution; Proteinuria; Puromycin aminonucleoside nephrosis

Indexed keywords

ALPHA ACTININ; DENDRIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; MEMBRANE PROTEIN; NEPHRIN; PLEKHH2 PROTEIN; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME INHIBITION; GLOMERULUS CAPILLARY; IMMUNOHISTOCHEMISTRY; KIDNEY PERFUSION; MALE; MEMBRANE PERMEABILITY; NEPHROSIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; PUROMYCIN AMINONUCLEOSIDE NEPHROSIS; QUANTITATIVE ANALYSIS; RAT; ULTRASTRUCTURE;

ACTININ; ANIMALS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MEMBRANE PROTEINS; NEPHROSIS; NERVE TISSUE PROTEINS; PERMEABILITY; PROTEINS; PROTEINURIA; PUROMYCIN AMINONUCLEOSIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77953937699     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317130     Document Type: Article

References (51)

1. Kestila M, Lenkkeri U, Mannikko M, Lamer-din J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kash-tan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein-nephrin-is mu-tated in congenital nephrotic syndrome. Mol Cell 1998; 1: 575-582.
2. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant ne-phrotic syndrome. Nat Genet 2000; 24: 349-354.
3. Donoviel DB, Freed DD, Vogel H, Potter DG, Hawkins E, Barrish JP, Mathur BN, Turner CA, Geske R, Montgomery CA, Starbuck M, Brandt M, Gupta A, Ramirez-Solis R, Zambrowicz BP, Powell DR: Proteinuria and perinatal lethality in mice lacking Neph1, a novel protein with homology to nephrin. Mol Cell Biol 2001; 21:4829-4836.
4. Ihalmo P, Schmid H, Rastaldi MP, Mattinzo-li D, Langham RG, Luimula P, Kilpikari R Lassila M, Gilbert RE, Kerjaschki D, Kretz-ler M, Holthofer H: Expression of filtrin in human glomerular diseases. Nephrol Dial Transplant 2007; 22: 1903-1909.
5. Inoue T, Yaoita E, Kurihara H, Shimizu F, Sakai T, Kobayashi T, Ohshiro K, Kawachi H, Okada H, Suzuki H, Kihara I, Yamamoto T: Fat is a component of glomerular slit dia-phragms. Kidney Int 2001; 59: 1003-1012.
6. Liu G, Kaw B, Kurfis J, Rahmanuddin S, Kanwar YS, Chugh SS: Neph-1 and nephrin interaction in the slit diaphragm is an im-portant determinant of glomerular perme-ability. J Clin Invest 2003; 112:209-221.
7. Reiser J, Polu KR, Moller CC, Kenlan P, Al-tintas MM, Wei C, Faul C, Herbert S, Ville-gas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R Mundel P, Smith PL, Clapham DE, Pollak MR: TRPC6 is a glo-merular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005; 37: 739-744.
8. Huber TB, Kwoh C, Wu H, Asanuma K Godel M, Hartleben B, Blumer KJ, Miner JH, Mundel P, Shaw AS: Bigenic mouse models of focal segmental glomerulosclerosis in-volving pairwise interaction of CD2AP, Fyn, and synaptopodin. J Clin Invest 2006; 116: 1337-1345.
9. Huber TB, Schmidts M, Gerke P, Schermer B, Zahn A, Hartleben B, Sellin L, Walz G, Benzing T: The carboxyl terminus of Neph family members binds to the PDZ domain protein zonula occludens-1. J Biol Chem 2003; 278: 13417-13421.
10. Jones N, Blasutig IM, Eremina V, Ruston JM, Bladt F, Li H, Huang H, Larose L, Li SS, Takano T, Quaggin SE, Pawson T: Nck adap-tor proteins link nephrin to the actin cyto-skeleton of kidney podocytes. Nature 2006; 440: 818-823.
11. Schnabel E, Anderson JM, Farquhar MG: The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epi-thelium. J Cell Biol 1990; 111: 1255-1263.
12. Shih N Y, Li J, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O, Miner JH, Shaw AS: Con-genital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999; 286: 312-315.
13. Verma R, Kovari I, Soofi A, Nihalani D, Pat-rie K, Holzman LB: Nephrin ectodomain en-gagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest 2006; 116:1346-1359.
14. Ryan G KMJ: An ultrastructural study of the mechanisms of proteinuria in aminonucleo-side nephrosis. Kidney Int 1975; 8:219-232.
15. Smoyer WE, Mundel P, Gupta A, Welsh MJ: Podocyte α-actinin induction precedes foot process effacement in experimental nephrotic syndrome. Am J Physiol 1997; 273:F150-F157.
16. Lahdenkari AT, Lounatmaa K, Patrakka J, Holmberg C, Wartiovaara J, Kestila M, Kos-kimies O, Jalanko H: Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol 2004; 15:2611-2618.
17. Saleem MA, Ni L, Witherden I, Tryggvason K, Ruotsalainen V, Mundel P, Mathieson PW: Co-localization of nephrin, podocin, and the actin cytoskeleton: evidence for a role in podocyte foot process formation. Am J Pathol 2002; 161:1459-1466.
18. Takemoto M, He L, Norlin J, Patrakka J, Xiao Z, Petrova T, Bondjers C, Asp J, Wallgard E, Sun Y, Samuelsson T, Mostad P, Lundin S, Miura N, Sado Y, Alitalo K, Quaggin SE, Tryggvason K, Betsholtz C: Large-scale iden-tification of genes implicated in kidney glomerulus development and function. EMBO J 2006; 25: 1160-1174.
19. Patrakka J, Xiao Z, Nukui M, Takemoto M, He L, Oddsson A, Perisic L, Kaukinen A, Al-Khaliliszigyarto C, Uhlen M, Jalanko H Betsholtz C, Tryggvason K: Expression and subcellular distribution of novel glomeru-lus-associated proteins dendrin, ehd3, sh2d4a, plekhh2, and 2310066E14Rik. J Am Soc Nephrol 2007; 18: 689-697.
20. Asanuma K, Campbell KN, Kim K, Faul C, Mundel P: Nuclear relocation of the nephrin and CD2AP-binding protein dendrin pro-motes apoptosis of podocytes. Proc Natl Acad Sci USA 2007; 104:10134-10139.
21. Duner F, Patrakka J, Xiao Z, Larsson J, Vla-mis-Gardikas A, Pettersson E, Tryggvason K, Hultenby K, Wernerson A: Dendrin ex-pression in glomerulogenesis and in human minimal change nephrotic syndrome. Nephrol Dial Transplant 2008; 23: 2504-2511.
22. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, Pollak MR: Mutations in ACTN4, encodingα-actinin-4, cause familial focal segmental glomerulo-sclerosis. Nat Genet 2000; 24:251-256.
23. Kobayashi N: Mechanism of the process for-mation; podocytes versus neurons. Microsc Res Tech 2002; 57: 217-223.
24. Johnsson E, Haraldsson B: An isolated per-fused rat kidney preparation designed for as-sessment of glomerular permeability charac-teristics. Acta Physiol Scand 1992; 144:65-73.
25. Lindstrom KE, Johnsson E, Haraldsson B: Glomerular charge selectivity for proteins larger than serum albumin as revealed by lactate dehydrogenase isoforms. Acta Physi-ol Scand 1998; 162:481-488.
26. Ohlson M, Sorensson J, Haraldsson B: A gel-membrane model of glomerular charge and size selectivity in series. Am J Physiol Renal Physiol 2001; 280:F396-F405.
27. Wernerson A, Duner F, Pettersson E, Wid-holm SM, Berg U, Ruotsalainen V, Trygg-vason K Hultenby K, Soderberg M: Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome. Nephrol Dial Transplant 2003; 18: 70-76.
28. Putaala H, Soininen R, Kilpelainen P, Wartiovaara J, Tryggvason K: The murine nephrin gene is specifically expressed in Kidney, brain and pancreas: Inactivation of the gene leads to massive proteinuria and neona-tal death. Hum Mol Genet 2001; 10:1-8.
29. Guan N, Ding J, Deng J, Zhang J, Yang J: Key molecular events in puromycin aminonucle-oside nephrosis rats. Pathol Int 2004; 54:703-711.
30. Hosoyamada M, Yan K, Nishibori Y, Takiue Y, Kudo A, Kawakami H, Shibasaki T, Endou H: Nephrin and podocin expression around the onset of puromycin aminonucleoside ne-phrosis. J Pharmacol Sci 2005; 97: 234-241.
31. Kawachi H, Koike H, Kurihara H, Yaoita E, Orikasa M, Shia MA, Sakai T, Yamamoto T, Salant DJ, Shimizu F: Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int 2000; 57: 1949-1961.
32. Luimula P, Ahola H, Wang SX, Solin ML, Aal-tonen P, Tikkanen I, Kerjaschki D, Holthofer H: Nephrin in experimental glomerular dis-ease. Kidney Int 2000; 58: 1461-1468.
33. Luimula P, Sandstrom N, Novikov D, Holthofer H: Podocyte-associated molecules in puromycin aminonucleoside nephrosis of the rat. Lab Invest 2002; 82: 713-718.
34. Praga M: Therapeutic measures in protein-uric nephropathy. Kidney Int Suppl 2005: S137-S141.
35. Tryggvason K, Pettersson E: Causes and con-sequences of proteinuria: the kidney filtra-tion barrier and progressive renal failure. J Intern Med 2003; 254: 216-224.
36. Benigni A, Tomasoni S, Gagliardini E, Zoja C, Grunkemeyer JA, Kalluri R, Remuzzi G: Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 2001; 12: 941-948.
37. Marinides GN GG, Cohen AH, Cook T, Ba-ranowski RL, Westenfelder C, Border WA: Failure of angiotensin converting enzyme inhibition to affect the course of puromycin aminonucleoside nephropathy. Am J Pathol 1987; 129: 394-401.
38. Marinides GN Groggel GC, Cohen AH, Bor-der WA: Enalapril and low protein reverse chronic puromycin aminonucleoside ne-phropathy. Kidney Int 1990; 37: 749-757.
39. Shinosaki T, Takagawa I, Sunagawa N, Yone-tani Y, Kurihara H: Dual effects of lisinopril on puromycin aminonucleoside nephrosis in unilaterally nephrectomized rats. Jpn J Phar-macol 1997; 73: 337-345.
40. Suzuki K, Han GD, Miyauchi N, Hashimoto T, Nakatsue T, Fujioka Y, Koike H, Shimizu F, Kawachi H: Angiotensin ii type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capil-lary wall. Am J Pathol 2007; 170:1841-1853.
41. Hjalmarsson C, Ohlson M, Haraldsson B: Puromycin aminonucleoside damages the glomerular size barrier with minimal effects on charge density. Am J Physiol Renal Physiol 2001; 281:F503-F512.
42. Carrie BJ, Salyer WR, Myers BD: Minimal change nephropathy: an electrochemical disorder of the glomerular membrane. Am J Med 1981; 70:262-268.
43. Haraldsson B, Nystrom J, Deen WM: Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008; 88: 451-487.
44. Harvey SJ, Miner JH: Revisiting the glomerular charge barrier in the molecular era. Curr Opin Nephrol Hypertens 2008; 17:393-398.
45. Nakakura H, Ashida A, Hirano K, Tamai H: Oxidative stress in a rat model of nephrosis can be quantified by electron spin resonance. Pediatr Nephrol 2004; 19: 266-270.
46. Marshall CB, Pippin JW, Krofft RD, Shank-land SJ: Puromycin aminonucleoside induc-es oxidant-dependent DNA damage in podo-cytes in vitro and in vivo. Kidney Int 2006; 70: 1962-1973.
47. Jia J, Ding G, Zhu J, Chen C, Liang W, Fran-ki N, Singhal PC: Angiotensin ii infusion in-duces nephrin expression changes and podo-cyte apoptosis. Am J Nephrol 2008; 28: 500-507.
48. Furness PN, Harris K: An evaluation of ex-perimental models of glomerulonephritis. Int J Exp Pathol 1994; 75: 9-22.
49. Pavenstadt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 2003; 83:253-307.
50. Whiteside C, Prutis K, Cameron R, Thompson J: Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis. Lab Invest 1989; 61:650-660.
51. Inokuchi S, Sakai T, Shirato I, Tomino Y, Koide H: Ultrastructural changes in glomer-ular epithelial cells in acute puromycin ami-nonucleoside nephrosis: a study by high-resolution scanning electron microscopy Virchows Arch A Pathol Anat Histopathol 1993; 423:111-119.